Format

Send to

Choose Destination
Stem Cell Res. 2019 Feb 27:101412. doi: 10.1016/j.scr.2019.101412. [Epub ahead of print]

Corrigendum to "Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD)" [Stem Cell Research 33(2018) 265-268].

Author information

1
Stem Cell Core Facility, Translational Medical Center for Stem Cell Therapy, China; Lab of stem cell and neurodegeneration, Tongji University School of Medicine, Shanghai, China; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
2
Department of Neurology, Shanghai East Hospital, China.
3
Stem Cell Core Facility, Translational Medical Center for Stem Cell Therapy, China.
4
Stem Cell Core Facility, Translational Medical Center for Stem Cell Therapy, China; Lab of stem cell and neurodegeneration, Tongji University School of Medicine, Shanghai, China. Electronic address: Jzhao@sibs.ac.cn.
PMID:
30826348
DOI:
10.1016/j.scr.2019.101412
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center